Vitamin K2 (menaquinone) has shown promising effects on diabetes in animal models. Does it hold up in humans?
In this 12-week randomized controlled trial, 45 patients with type 2 diabetes took either 200 μg of vitamin K2 or a placebo. Markers of cardiovascular and metabolic health such as blood pressure, HbA1c, and blood lipids were measured at baseline and 12 weeks.
Get free weekly updates on what’s new at Examine.
This Study Summary was published on September 4, 2020.